  Although cognitive dysfunction is a leading cause of disability and poor quality of life in patients with multiple sclerosis ( MS) , it is infrequently tested in routine clinical evaluation. Development of a cognitive testing paradigm that captured MS-related cognitive dysfunction and could be obtained in a routine clinical setting may increase surveillance and recognition of cognitive dysfunction. This was a pilot study to determine if Significant differences were found between MS and HC on SDMT , PASAT , and None